Dr. Lothar Lilge to Present at International Photodynamic Association World Congress
MBP researcher Dr. Lothar Lilge will be presenting at the 17th International Photodynamic Association ("IPA") World Congress, to be held in Cambridge, Massachusetts from June 28th to July 4th, 2019.
Dr. Lilge, who is an esteemed PDT expert and a member of the Medical and Scientific Advisory Board ("MSAB"), was elected to be a Co-Chairman of the Urology Session at the Congress and has been invited to deliver a presentation entitled, "Improving the Safety and Efficacy of PhotoDynamic Therapy of Bladder Cancer – Light Dosimetry Aspects of a Phase Ib Study Using Intravesical TLD-1433 (a Ruthenium (II)-Based Photosensitizer) in Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients".
Dr. Lilge's presentation will focus on the laser dosimetry utilized and clinical outcomes of the Study. In addition, Dr. Lilge will discuss applications of Theralase's Anti-Cancer Technology ("ACT") to other cancers, as well as the potential for a combination of Theralase's lead PDC, TLD-1433, with various physical therapeutic modalities.